Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy-Reference-Cited by-同舟云学术

Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy

Published:2018-03-15 Issue:5 Volume:47 Page:351-359
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Fedele AL¹,Petricca L¹,Tolusso B¹,Alivernini S¹,Canestri S¹,Di Mario C¹,Bosello SL¹,Ferraccioli G¹,Gremese E¹

Affiliation:

1. Division of Rheumatology, Catholic University of the Sacred Heart, Agostino Gemelli University Polyclinic, Rome, Italy

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2017.1416668

Reference41 articles.

1. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

2. Elevated IgA Plasmablast Levels in Subjects at Risk of Developing Rheumatoid Arthritis

3. Editorial: IgA Responses and Future Development of Rheumatoid Arthritis

4. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoantibodies Serum Level and 10-Year Risk of Fractures Evaluated by FRAX® Tool in Rheumatoid Arthritis Patients;Open Access Rheumatology: Research and Reviews;2024-07

2. In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation;Annals of the Rheumatic Diseases;2023-11-27

3. Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium”;Journal of Clinical Medicine;2023-04-09

4. What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis;RMD Open;2023-04

5. The forgotten key players in rheumatoid arthritis: IL-8 and IL-17 – Unmet needs and therapeutic perspectives;Frontiers in Medicine;2023-03-22